Doses of intravenous valproic acid in a neonate

I. Alfonso, L. Alvarez, K. Yelin, J. T. Gilman, F. Estrada

Research output: Contribution to journalArticle

Abstract

The dose of intravenous valproic acid required to achieve a desired serum concentration in neonates has not been established. We report the serum valproic acid concentrations reached 3 hours after intravenous valproic acid infusions on four different occasions in a neonate with Otahara syndrome. The patient was on a maintenance dose of valproic acid of 10 mg/kg per day in three divided doses by nasogastric tube. The serum valproic acid concentrations increased 35, 46, 66, and 49 μg/mL (242.5, 318.8, 457.4, 339.6 μmol/L), 3 hours after a dose of 10, 15, 20, and 10 mg/kg, respectively. During the first and second trials 10 mg of valproic acid by nasogastric tube were given prior to the intravenous doses. During the fourth trial 45 mg of valproic acid by nasogastric tube was given 45 minutes after the intravenous dose. This trial was excluded from the calculations. No valproic acid by nasogastric tube was given during the third trial. We conclude that in this patient, each 1 mg of intravenous valproic acid increased the 3-hour post-infusion serum valproic acid concentration by 3.3 ± 0.2 μg/mL. We propose that this ratio be used to calculate the valproic acid dose in neonates until further clinical trials are conducted.

Original languageEnglish
Pages (from-to)52-53
Number of pages2
JournalInternational Pediatrics
Volume14
Issue number1
StatePublished - Jan 1 1999

Fingerprint

Valproic Acid
Newborn Infant
Serum
Clinical Trials

Keywords

  • Dose
  • Intravenous
  • Otohara syndrome
  • Valproic acid

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Alfonso, I., Alvarez, L., Yelin, K., Gilman, J. T., & Estrada, F. (1999). Doses of intravenous valproic acid in a neonate. International Pediatrics, 14(1), 52-53.

Doses of intravenous valproic acid in a neonate. / Alfonso, I.; Alvarez, L.; Yelin, K.; Gilman, J. T.; Estrada, F.

In: International Pediatrics, Vol. 14, No. 1, 01.01.1999, p. 52-53.

Research output: Contribution to journalArticle

Alfonso, I, Alvarez, L, Yelin, K, Gilman, JT & Estrada, F 1999, 'Doses of intravenous valproic acid in a neonate', International Pediatrics, vol. 14, no. 1, pp. 52-53.
Alfonso I, Alvarez L, Yelin K, Gilman JT, Estrada F. Doses of intravenous valproic acid in a neonate. International Pediatrics. 1999 Jan 1;14(1):52-53.
Alfonso, I. ; Alvarez, L. ; Yelin, K. ; Gilman, J. T. ; Estrada, F. / Doses of intravenous valproic acid in a neonate. In: International Pediatrics. 1999 ; Vol. 14, No. 1. pp. 52-53.
@article{63eb389510d0491ab9b13607b63ce59e,
title = "Doses of intravenous valproic acid in a neonate",
abstract = "The dose of intravenous valproic acid required to achieve a desired serum concentration in neonates has not been established. We report the serum valproic acid concentrations reached 3 hours after intravenous valproic acid infusions on four different occasions in a neonate with Otahara syndrome. The patient was on a maintenance dose of valproic acid of 10 mg/kg per day in three divided doses by nasogastric tube. The serum valproic acid concentrations increased 35, 46, 66, and 49 μg/mL (242.5, 318.8, 457.4, 339.6 μmol/L), 3 hours after a dose of 10, 15, 20, and 10 mg/kg, respectively. During the first and second trials 10 mg of valproic acid by nasogastric tube were given prior to the intravenous doses. During the fourth trial 45 mg of valproic acid by nasogastric tube was given 45 minutes after the intravenous dose. This trial was excluded from the calculations. No valproic acid by nasogastric tube was given during the third trial. We conclude that in this patient, each 1 mg of intravenous valproic acid increased the 3-hour post-infusion serum valproic acid concentration by 3.3 ± 0.2 μg/mL. We propose that this ratio be used to calculate the valproic acid dose in neonates until further clinical trials are conducted.",
keywords = "Dose, Intravenous, Otohara syndrome, Valproic acid",
author = "I. Alfonso and L. Alvarez and K. Yelin and Gilman, {J. T.} and F. Estrada",
year = "1999",
month = "1",
day = "1",
language = "English",
volume = "14",
pages = "52--53",
journal = "International Pediatrics",
issn = "0885-6265",
publisher = "Miami Children's Hospital Medical Journal Inc.",
number = "1",

}

TY - JOUR

T1 - Doses of intravenous valproic acid in a neonate

AU - Alfonso, I.

AU - Alvarez, L.

AU - Yelin, K.

AU - Gilman, J. T.

AU - Estrada, F.

PY - 1999/1/1

Y1 - 1999/1/1

N2 - The dose of intravenous valproic acid required to achieve a desired serum concentration in neonates has not been established. We report the serum valproic acid concentrations reached 3 hours after intravenous valproic acid infusions on four different occasions in a neonate with Otahara syndrome. The patient was on a maintenance dose of valproic acid of 10 mg/kg per day in three divided doses by nasogastric tube. The serum valproic acid concentrations increased 35, 46, 66, and 49 μg/mL (242.5, 318.8, 457.4, 339.6 μmol/L), 3 hours after a dose of 10, 15, 20, and 10 mg/kg, respectively. During the first and second trials 10 mg of valproic acid by nasogastric tube were given prior to the intravenous doses. During the fourth trial 45 mg of valproic acid by nasogastric tube was given 45 minutes after the intravenous dose. This trial was excluded from the calculations. No valproic acid by nasogastric tube was given during the third trial. We conclude that in this patient, each 1 mg of intravenous valproic acid increased the 3-hour post-infusion serum valproic acid concentration by 3.3 ± 0.2 μg/mL. We propose that this ratio be used to calculate the valproic acid dose in neonates until further clinical trials are conducted.

AB - The dose of intravenous valproic acid required to achieve a desired serum concentration in neonates has not been established. We report the serum valproic acid concentrations reached 3 hours after intravenous valproic acid infusions on four different occasions in a neonate with Otahara syndrome. The patient was on a maintenance dose of valproic acid of 10 mg/kg per day in three divided doses by nasogastric tube. The serum valproic acid concentrations increased 35, 46, 66, and 49 μg/mL (242.5, 318.8, 457.4, 339.6 μmol/L), 3 hours after a dose of 10, 15, 20, and 10 mg/kg, respectively. During the first and second trials 10 mg of valproic acid by nasogastric tube were given prior to the intravenous doses. During the fourth trial 45 mg of valproic acid by nasogastric tube was given 45 minutes after the intravenous dose. This trial was excluded from the calculations. No valproic acid by nasogastric tube was given during the third trial. We conclude that in this patient, each 1 mg of intravenous valproic acid increased the 3-hour post-infusion serum valproic acid concentration by 3.3 ± 0.2 μg/mL. We propose that this ratio be used to calculate the valproic acid dose in neonates until further clinical trials are conducted.

KW - Dose

KW - Intravenous

KW - Otohara syndrome

KW - Valproic acid

UR - http://www.scopus.com/inward/record.url?scp=0033001313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033001313&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033001313

VL - 14

SP - 52

EP - 53

JO - International Pediatrics

JF - International Pediatrics

SN - 0885-6265

IS - 1

ER -